{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:46:16Z","timestamp":1792079176483,"version":"4.4.0"},"reference-count":24,"publisher":"American Society of Tropical Medicine and Hygiene","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>Persistent magnetic resonance imaging (MRI) abnormalities after treatment of intracranial tuberculomas create uncertainty regarding the optimal duration of antituberculous therapy (ATT). We systematically reviewed evidence on treatment duration, persistent residual lesions, and factors leading to treatment prolongation from case reports, case series, and cohort studies reporting intracranial tuberculomas treated with ATT. The review included 124 reports describing 201 patients with intracranial tuberculomas, 39 reports of miliary brain tuberculomas, and 24 cohort studies. Complete radiological resolution at the completion of ATT occurred in 71 of 201 patients, whereas persistent residual lesions remained in 83 of 201, and there was progressive disease in 11 of 201. Paradoxical reactions developed in 94 of 201 patients and were the most common indication for treatment extension. Although 39 of 201 patients completed 12 months of ATT, 31 received 13 to 18 months, 28 received 19 to 24 months, and 24 received &gt;24 months. Complete clinical and radiological recovery was achieved in 99 of 201, whereas 75 of 201 improved despite residual sequelae; recurrence occurred in only 7 of 201. Among the 24 cohort studies, 20 reported radiological outcomes. Of these, persistent residual lesions were reported in 16 studies, whereas 4 reported complete radiological resolution. Planned ATT ranged from 6 to 18 months, paradoxical reactions ranged from 3.4% to 51%, and mortality varied up to 23.1%. Persistent intracranial tuberculomas are common after standard ATT and frequently result in prolonged treatment. Our review indicates that persistent MRI abnormalities alone should not be used to determine treatment duration.<\/jats:p>","DOI":"10.4269\/ajtmh.26-0427","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:11:18Z","timestamp":1792077078000},"source":"Crossref","is-referenced-by-count":0,"title":["Persistent Brain Tuberculomas after Standard Antituberculous Therapy: A Systematic Review of Radiological Persistence, Treatment Duration, and Clinical Outcomes"],"prefix":"10.4269","author":[{"given":"Ravindra Kumar","family":"Garg","sequence":"first","affiliation":[{"name":"Department of Neurology, Era\u2019s Lucknow Medical College & Hospital, Era University, Lucknow, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Neurology, King George\u2019s Medical University, Lucknow, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Department of Neurology, King George\u2019s Medical University, Lucknow, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singhal","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Sanjay Gandhi Institute of Medical Sciences, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"issue":"2","key":"b1","series-title":"Indian J Tuberc","first-page":"270","article-title":"Challenges and advancements in the diagnosis of central nervous system tuberculosis","volume":"73","author":"Garg","year":"2026"},{"key":"b2","article-title":"WHO Operational Handbook on Tuberculosis: Module 4: Treatment and Care.","year":"2025"},{"issue":"1","key":"b3","series-title":"J Neurosurg","first-page":"15","article-title":"Central nervous system tuberculosis: A persistent disease","volume":"34","author":"Wilkinson","year":"1971"},{"issue":"4","key":"b4","series-title":"Neurosurgery","first-page":"873","article-title":"Rate of resolution of histologically verified intracranial tuberculomas","volume":"53","author":"Poonnoose","year":"2003"},{"key":"b5","series-title":"Wellcome Open Res","first-page":"158","article-title":"Management of intracranial tuberculous mass lesions: How long should we treat for?","volume":"4","author":"Marais","year":"2019"},{"issue":"2","key":"b6","series-title":"Int J Tuberc Lung Dis","first-page":"224","article-title":"Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting","volume":"24","author":"Marais","year":"2020"},{"issue":"4","key":"b7","series-title":"Infection","first-page":"2135","article-title":"Radiographic resolution of presumed cerebellar tuberculoma during extended BPaLM-based therapy for disseminated multidrug-resistant tuberculosis","volume":"54","author":"Flowers","year":"2026"},{"issue":"12","key":"b8","series-title":"Cureus","first-page":"e20133","article-title":"Diagnostic and neurological overview of brain tuberculomas: A review of literature","volume":"13","author":"Perez-Malagon","year":"2021"},{"key":"b9","series-title":"World Neurosurg","first-page":"e236","article-title":"Factors predicting the need for prolonged (>24 months) antituberculous treatment in patients with brain tuberculomas","volume":"125","author":"Nair","year":"2019"},{"key":"b10","series-title":"SAGE Open Med Case Rep","first-page":"2050313X18823092","article-title":"Duration of anti-tuberculous therapy in children with persistent tuberculomas","volume":"7","author":"Shah","year":"2019"},{"issue":"1","key":"b11","series-title":"J Neurol Sci","first-page":"47","article-title":"Evolution of brain tuberculomas under standard antituberculous treatment","volume":"156","author":"Awada","year":"1998"},{"key":"b12","article-title":"Brain Tuberculoma: A Systematic Review of Treatment Regimens, Duration of Therapy, Lesion Persistence, and Clinical Outcomes.","author":"Garg","year":"2026"},{"issue":"5","key":"b13","series-title":"Neuroradiol J","first-page":"556","article-title":"The etiological spectrum of miliary brain lesions: A systematic review of published cases and case series","volume":"37","author":"Garg","year":"2024"},{"issue":"2","key":"b14","series-title":"BMJ Evid Based Med.","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018"},{"issue":"9","key":"b15","series-title":"Eur J Epidemiol.","first-page":"603","article-title":"Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010"},{"issue":"3","key":"b16","series-title":"Neurosurg Rev","first-page":"103","article-title":"Neurosurgically relevant aspects of pathology and pathogenesis of intracranial and intraspinal tuberculosis","volume":"6","author":"Dastur","year":"1983"},{"issue":"3","key":"b17","series-title":"J Neurol Sci","first-page":"575","article-title":"Pathological analysis of intracranial space-occupying lesions in 1000 cases including children. 1. Age, sex and pattern; and the tuberculomas","volume":"6","author":"Dastur","year":"1968"},{"issue":"5","key":"b18","series-title":"Clin Radiol","first-page":"354","article-title":"Intracranial tuberculomas: Review of MRI findings and clinical features","volume":"79","author":"Koesbandono","year":"2024"},{"issue":"1","key":"b19","series-title":"Int J Tuberc Lung Dis","first-page":"91","article-title":"Tuberculoma of the brain: A series of 16 cases treated with anti-tuberculosis drugs","volume":"11","author":"Idris","year":"2007"},{"issue":"5","key":"b20","series-title":"Am J Trop Med Hyg","first-page":"1141","article-title":"Clinical and radiological end points to stop anti-tubercular treatment in central nervous system tuberculoma and predictors of poor outcome: A retrospective study","volume":"109","author":"Gupta","year":"2023"},{"issue":"12","key":"b21","series-title":"Lancet Infect Dis","first-page":"795","article-title":"Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis","volume":"5","author":"Nicolls","year":"2005"},{"issue":"1\u20132","key":"b22","series-title":"J Neurol Sci","first-page":"26","article-title":"Paradoxical reaction in HIV negative tuberculous meningitis","volume":"340","author":"Garg","year":"2014"},{"issue":"8","key":"b23","series-title":"Med Mal Infect","first-page":"533","article-title":"Contribution of brain imaging to the diagnosis of intracranial tuberculoma and other brain lesions in patients presenting with miliary tuberculosis","volume":"48","author":"Bleibtreu","year":"2018"},{"issue":"6","key":"b24","series-title":"Am J Trop Med Hyg","first-page":"1264","article-title":"Large tuberculous mass lesions involving the brain: Outcomes and management","volume":"112","author":"Palanikumar","year":"2025"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/aop\/article-10.4269-ajtmh.26-0427\/article-10.4269-ajtmh.26-0427.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/aop\/article-10.4269-ajtmh.26-0427\/article-10.4269-ajtmh.26-0427.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:11:18Z","timestamp":1792077078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/aop\/article-10.4269-ajtmh.26-0427\/article-10.4269-ajtmh.26-0427.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":24,"URL":"https:\/\/doi.org\/10.4269\/ajtmh.26-0427","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}